Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Key highlights 50+ years
Like any medical treatment, lipotropic injections carry potential risks, and they are not appropriate for everyone
Concentration accuracy at the 0.9% level requires pharmaceutical-grade manufacturing controls that a standard lab cannot replicate reliably
Generic or undated COAs, or those from in-house labs only, are insufficient verification
In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)
US$ 22.67
US$ 22.05
US$ 20.51
US$ 24.23
US$ 21.68
US$ 21.49
US$ 20.30
